Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome

Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome

Abstract Background Acute chest syndrome (ACS) is the leading cause of mortality in sickle cell disease (SCD). The pathogenesis of ACS is complex and not entirely understood with multiple etiologies likely contributing simultaneously. One particular etiology is pulmonary vascular occlusion due to th...

Full description

Bibliographic Details
Main Authors: Craig D. Seaman, Enrico Novelli, Laura De Castro, Margaret V. Ragni
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Pilot and Feasibility Studies
Subjects:
Acute chest syndrome
Heparin
Sickle cell disease
Thrombosis
Online Access:http://link.springer.com/article/10.1186/s40814-020-00715-w

Internet

http://link.springer.com/article/10.1186/s40814-020-00715-w

Similar Items